NHS leaders have warned that the costs associated with ADHD and autism are becoming “out of control,” highlighting fresh concern about the strain on health and care services in England. The warning comes as the system continues to grapple with rising demand for neurodevelopmental assessment and support, with leaders arguing that current pressures are no longer limited to one part of the pathway but are affecting services more broadly.
The BMJ reported on September 1, 2026, that NHS leaders are sounding the alarm over the scale of spending linked to ADHD and autism, putting the issue firmly back on the agenda for clinicians, commissioners and policymakers. The concern reflects a wider debate about how the health service should balance timely assessment, appropriate diagnosis and the long-term support patients may need after diagnosis. Read the BMJ news listing
Growing demand is testing the limits of current pathways
In recent years, services dealing with neurodevelopmental conditions have faced intense scrutiny over waiting times, referral thresholds and the capacity of specialist teams. The latest warning suggests that the financial impact is becoming a major part of that conversation, not just the operational burden. For NHS leaders, the issue is not simply how many people are being referred, but how the system can sustainably manage the volume of assessments, follow-up care and support packages that may follow.
That concern matters because ADHD and autism services sit at the intersection of education, social support and healthcare. When demand rises sharply, pressures can spread across general practice, specialist mental health teams, schools and local authority services. The result is often a system in which patients and families wait longer while professionals try to preserve safe, evidence-based care.
Why the warning matters for patients and clinicians
For patients, the impact of stretched services can be delayed diagnosis, fragmented support and uncertainty about the next step in care. For clinicians, particularly those working in primary care and community settings, the challenge is to respond appropriately to rising need while operating within limited resources. NHS leaders’ warning points to a broader question: how can the health system ensure that people who genuinely need assessment and ongoing care can access it without overwhelming already pressured services?
The debate is likely to continue as NHS leaders look for ways to control costs while maintaining access and quality. At present, the concern over ADHD and autism spending is part of a wider pattern across UK healthcare, where demand for specialist services continues to outpace capacity in many areas.
The latest warning does not offer a simple solution, but it does underline the scale of the challenge facing the NHS. As pressure rises, the central task for policymakers will be to design care pathways that are clinically robust, financially sustainable and capable of meeting need without creating further delays elsewhere in the system.
Photo source: AI-generated or edited image
